The U.S. Food and Drug Administration (FDA) approved the Barostim Neo System for the improvement of symptoms in patients with advanced heart failure who are not suited for treatment with other...
EP Lab
This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.
-
-
Abbott is recalling the Ellipse Implantable Cardioverter Defibrillators (ICDs) because electrical failures have been identified and determined to be due to a faulty manufacturing process, causing...
-
Mark Ibrahim, M.D., FACC, assistant professor of medicine and radiology, associate program director...
-
Pierre Qian, MBBS, cardiac electrophysiologist fellow, Brigham and Women's Hospital, explains how...
News | Leads Implantable Devices | September 20, 2019
September 20, 2019 — BioTrace Medical Inc. announced the company’s key activities at the 31st annual...
News | Heart Failure | September 20, 2019
September 20, 2019 — The new Max and Debra Ernst Heart Center at Beaumont Hospital, Royal Oak, Mich., will open Sept...
News | Implantable Cardioverter Defibrillator (ICD) | September 18, 2019
September 18, 2019 — Early use of an...
Sponsored Content
Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.
Feature | Sudden Cardiac Arrest | October 16, 2018
Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent...
News | Ablation Systems | September 17, 2019
September 17, 2019 — Treating high-risk heart patients with a single, high dose of radiation therapy can...
InfoBionic’s MoMe Kardia remote ECG monitor is an example of the newer generation devices that are replacing traditional Holter monitors. It has a single button for patients to create an alert when they are experiencing arrhythmia symptoms.
Feature | ECG Wireless Remote Access | August 30, 2019 | Stuart Long and Colin Movsowitz, M.D.
Until recently, cardiologists trying to diagnose and treat arrhythmias have had to deal with technological limitations...
The Apple Watch is being used to help identify and track Afib in the general population.
Blog | Wearables | August 29, 2019
Sponsored Content
An example of the new generation of cardiac monitoring device that is replacing Holter monitoring is the Cardea Solo wearable sensor. The FDA-cleared device automatically analyzes data when the device is turned back into the physician's office and automatically produces a draft summary report. This technology can simplify the workflow by eliminating the need for third-party involvement.
Feature | Atrial Fibrillation | September 13, 2018
Rapid advances in technology to monitor atrial fibrillation (AF or Afib) are enabling clinicians to access real-time...
News | EP Lab | August 27, 2019
August 27, 2019 – Lenox Hill Hospital (New York, N.Y.) has established a brand new Heart Rhythm Center dedicated to...
Similar to a pacemaker, the Barostim Neo System uses a pulse generator implanted below the collar bone with a lead that attaches to the carotid artery in the neck. It delivers electrical impulses to baroreceptors in the neck, which sense how blood is flowing through the carotid arteries and relays information to the brain. The brain, in turn, sends signals to the heart and blood vessels that relax the blood vessels and inhibit the production of stress-related hormones to reduce heart failure symptoms.
Technology | Heart Failure | August 19, 2019
August 19, 2019 — The U.S. Food and Drug Administration (FDA) granted market clearance the Barostim Neo...
The OPTIMA (Optimal Target Identification via Modelling of Arrhythmogenesis) simulator uses contrast-enhanced MRI scans to create personalized digital replicas of a patient's heart to guide catheter abation for atrial fibrillation. Image courtesy of Patrick M. Boyle and Natalia A. Trayanova.
News | EP Mapping and Imaging Systems | August 19, 2019
August 19, 2019 — Scientists at Johns Hopkins have successfully created...
Sponsored Content
An example of an automated summary cardiac monitor report from Medicalgorithmics' PocketECG system. Most of the the report parameters can be opened as separate pages with additional automated report summaries and graphical data charts.
Blog | Remote Monitoring | June 20, 2018
There is a movement toward real-time, remote cardiac monitoring with the latest generation of...
Researchers at Texas Heart Institute and Rice University have confirmed that flexible, conductive fibers made of carbon nanotubes can bridge damaged tissue to deliver electrical signals and keep hearts beating despite congestive heart failure or dilated cardiomyopathy or after a heart attack. Image courtesy of Texas Heart Institute.
News | EP Lab | August 15, 2019
August 15, 2019 — Thin, flexible fibers made of carbon nanotubes have now proven able to bridge damaged heart...
News | Leads Implantable Devices | August 05, 2019
August 5, 2019 — Abbott is recalling the Ellipse...
News | EP Lab | July 31, 2019
July 31, 2019 — The chances of patients experiencing complications after having a cardiac device implanted vary...
Sponsored Content
The Medicalgorithmics PocketECG Holter monitor offers real-time, remote, wireless ECG recording and tracking. Real-time data review may be able to help diagnose an arrhythmia quickly, reducing the amount of time the patient needs to be monitored. Also, 24/7 data offers a more complete picture of the patient's health, rather than fragments of data from older Holter and event monitor systems.
Blog | ECG Wireless Remote Access | June 06, 2018
There is a shift occurring in...
Videos | EP Lab | July 26, 2019
Videos | EP Lab | July 25, 2019
Dr. Markus Krane, deputy director of the Cardiac and Vascular Surgery Unit at the DHM helped compile an atlas of the heart and discovered myosin binding protein H-like (MYBPHL) occurs only in the atria of the heart. Researchers began using it as a blood test biomarker to assess the success of atrial fibrillation ablation procedures.
Feature | Atrial Fibrillation | July 24, 2019
July 24, 2019 — Atrial fibrillation (AFib) is a common abnormal heart rhythm. It is treated either with medications...
